Integrated Renal Sciences Private Limited - Due diligence report

A 360° intelligence report on Integrated Renal Sciences Private Limited: trust score, financial health, credit view, compliance, directors, …

2018-03-16 New Delhi, Delhi Active Unlisted Active Compliant
Share
Connect MCP
IR Integrated Renal Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Integrated Renal Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Integrated Renal Sciences Private Limited is assessed as Low Risk with a Trust Score of 78/100. Integrated Renal Sciences Private Limited is an active private limited indian non-government company incorporated in 2018, operating in the Healthcare sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 17 Aug 2026 from the latest processed filings. Integrated Renal Sciences Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
VIKAS VERMA 01234567 Director 01/04/2018 6 yrs Approved
ASHISH TYAGI 01234567 Director 01/04/2018 6 yrs Approved
RAKESH KUMAR THAKUR 01234567 Director 01/04/2018 6 yrs Approved
MAYANK SHARMA 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Dicopa Healthcare Private Limited
Subsidiaries
2
Group entities
2
Capital events
15 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Renmed Healthcare Private Limited Subsidiary Company 74.00%
Dicopa Healthcare Private Limited Holding Company 74.00%
Integrated Kidney Solutions Private Limited Subsidiary Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 75
Growth signals & trust indicators
Latest year revenue grew 38%.
Asset base grew 1.42 - capacity expansion.
Operating for 8 years.
Distress signals & risk flags
Losses deepening year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view66/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
26 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
10 Sep 2022
Securities allotted
58309 Preference Shares - 2.00 cr raised
20 Jul 2022
Securities allotted
27696 Preference Shares - 95.00 Lakh raised
01 Jul 2022
Securities allotted
26239 Preference Shares - 90.00 Lakh raised
09 May 2022
Securities allotted
53935 Preference Shares - 1.85 cr raised
23 Feb 2022
Securities allotted
36443 Preference Shares - 1.25 cr raised
27 Dec 2021
Securities allotted
55393 Preference Shares - 1.90 cr raised
27 Nov 2021
Director ceased
VIKAS VERMA
Director ceased
MAYANK SHARMA
21 Aug 2021
Securities allotted
102040 Preference Shares - 3.50 cr raised
25 May 2021
Director appointed
VIKAS VERMA (Director)
Director appointed
MAYANK SHARMA (Director)
24 May 2021
Securities allotted
87463 Preference Shares - 3.00 cr raised
22 Jan 2021
Securities allotted
24781 Preference Shares - 85.00 Lakh raised
10

Key Observations

Auto-generated from the data above
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
Operates a group structure with 2 subsidiary(ies) - assess on a consolidated basis.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 15 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Fhc Renal Care Private Limited U85200KL2022PTC073917 Kozhikode, Kerala, India
Guru Nanak Dialysis Center India Private Limited U85300PB2020PTC052340 Malerkotla, Punjab, India
Aarushi Lithotripsy Private Limited U85110KA2005PTC036093 Bangalore, Karnataka, India
Mission Nephro-Uro Care Private Limited U85190MH2010PTC208842 Mumbai, Maharashtra, India
Dharma Kidney Care And Research Private Limited U85110KA2014PTC076788 Bangalore, Karnataka, India
Gursewa Dialysis India Limited U85300DL2021PLC384867 New Delhi, Delhi, India
Nipro India Healthcare R&D Skill Center Private Limited U85200TG2019PTC135447 Rangareddy, Telangana, India
Preveta Healthcare Private Limited U74999DL2017PTC325586 Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Integrated Renal Sciences Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Integrated Renal Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 65/100, margin trends, ownership structure and peer set for Integrated Renal Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Integrated Renal Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Integrated Renal Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Integrated Renal Sciences Private Limited an active company?

Integrated Renal Sciences Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Integrated Renal Sciences Private Limited financially healthy?

Integrated Renal Sciences Private Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Integrated Renal Sciences Private Limited?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Integrated Renal Sciences Private Limited?

The ultimate holding entity is Dicopa Healthcare Private Limited. 4 active director(s) are on record.

Does Integrated Renal Sciences Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Integrated Renal Sciences Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Integrated Renal Sciences Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.